Table 1 LTL related to the clinicopathologic parameters of NSCLC patients.

From: Leukocyte telomere length serves as the novel prognostic biomarker for the resectable NSCLC

Parameter

Sample (n)

LTL median (IQR)

p-value

Age (years)

   

≥ 61

34

2.110 (1.638 to 2.320)

0.4264

<61

33

2.020 (1.185 to 2.275)

 

Not available

9

  

Gender

Male

43

2.040 (1.270 to 2.220)

0.6565

Female

24

2.210 (1.198 to 2.333)

 

Not available

9

  

Smoking

Yes

30

2.035 (1.220 to 2.320)

0.9975

No

37

2.100 (1.315 to 2.305)

 

Not available

9

  

Histology

AC

38

1.985 (1.178 to 2.303)

0.5008

SCC

21

2.190 (1.515 to 2.350)

 

Others

8

2.135 (1.938 to 2.293)

 

Not available

9

  

T stage

T1

24

2.145 (1.655 to 2.340)

0.3372

T2

34

2.005 (1.178 to 2.318)

 

T3

5

2.040 (1.510 to 2.475)

 

T4

4

1.490 (1.078 to 2.105)

 

Not available

9

  

LN metastasis

N0

35

2.210 (1.960 to 2.370)

0.0028*

N1

11

1.990 (1.380 to 2.210)

 

N2

21

1.760 (1.140 to 2.125)

 

Not available

9

  

Distant metastasis

M0

62

2.085 (1.515 to 2.318)

0.0030*

M1

5

1.180 (0.640 to 1.490)

 

Not available

9

  

TNM stage

I

25

2.220 (1.965 to 2.370)

0.0008*

II

16

2.135 (1.920 to 2.308)

 

III

21

1.880 (1.145 to 2.200)

 

IV

5

1.180 (0.640 to 1.490)

 

Not available

9

  
  1. *p < 0.05.
Back to article page